Antibiotics Archives - Infectious Diseases Hub

4 June, 2019 0

The ASPECT-NP study, rationale, results and repercussions – an interview with Igancio Martin-Loeches and Marin Kollef

ECCMID 2019 saw the first presentation of the results from ASPECT-NP, a randomized, multi-center Phase III trial evaluating Merck’s ZERBAXA® (ceftolozane–tazobactam) for the treatment of patients with ventilated nosocomial pneumonia. In light of this we spoke to investigators Marin Kollef and Ignacio Martin-Loeches about the rationale behind this trial, its design and the key findings.

News

30 May, 2019 0

FDA rejects Nabriva’s antibiotic Contepo for complicated UTIs: May’s industry headlines

Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.

Antimicrobial Resistance

14 May, 2019 0

Infographic: Antibiotic resistance & us

Take a look at our latest infographic where Annabelle Lopez explains what antibiotics are, how resistance occcurs and what the consequences might be without any action.

Clinical

13 May, 2019 0

Preventative antibiotics after assisted childbirth could prevent almost half of maternal infections

Giving a single dose of preventative antibiotics after assisted childbirth could prevent almost half of maternal infections and also reduce antibiotic use by infection prevention, according to a new trial.

Antimicrobial Resistance

7 May, 2019 0

Countering antibiotic tolerance to fight resistance

Antibiotic tolerance significantly reduces antibiotic efficacy and contributes to treatment failure; targeting both antibiotic tolerance and antibiotic resistance is critical to develop new antimicrobial strategies that will successfully eradicate hard-to-treat infections.

Bacterial

2 May, 2019 0

Gentamicin–azithromycin combination could be effective for drug-resistant gonorrhea

New research has suggested that a combination treatment of gentamicin with azithromycin was almost as effective as the currently used ceftriaxone for treating genital gonorrhea.

News

30 April, 2019 0

Positive opinions from US FDA and EMA for ViiV Healthcare’s Dovato®: April’s industry headlines

Take a look at this month’s industry headlines including news from ViiV Healthcare on long-acting and single dose formulations, sales for Eli Lilly and the possible development of a plague vaccine.

Outcomes Research

24 April, 2019 0

Is there a link between antibiotic use and cardiovascular disease?

Long durations of antibiotic use in middle- and late-adulthood have been linked to an increased risk of cardiovascular events in new research studying over 36,000 women.

Diagnosis

12 April, 2019 0

ECCMID19: Patients treated for suspected UTIs often lack evidence of infection

Only one-third of patients entering the emergency department with a suspected UTIs actually have evidence of infection, however, almost all were treated with antibiotics, according to research presented at ECCMID.

News

28 March, 2019 0

Phase III study of Novavax’s RSV vaccine fails primary objective: March’s industry headlines

Take a look at this month’s industry headlines including news on Sanofi’s Dengvaxia® vaccine from the USA and the Philippines, clinical trial results for RSV vaccines and HIV injectables and new acquisitions for Merck.

Microbiome therapeutics – the pipeline for C. difficile infection

Browsing: Antibiotics

The ASPECT-NP study, rationale, results and repercussions – an interview with Igancio Martin-Loeches and Marin Kollef

FDA rejects Nabriva’s antibiotic Contepo for complicated UTIs: May’s industry headlines

Infographic: Antibiotic resistance & us

Preventative antibiotics after assisted childbirth could prevent almost half of maternal infections

Countering antibiotic tolerance to fight resistance

Gentamicin–azithromycin combination could be effective for drug-resistant gonorrhea

Positive opinions from US FDA and EMA for ViiV Healthcare’s Dovato®: April’s industry headlines

Is there a link between antibiotic use and cardiovascular disease?

ECCMID19: Patients treated for suspected UTIs often lack evidence of infection

Phase III study of Novavax’s RSV vaccine fails primary objective: March’s industry headlines

Thank you for subscribing, your log-in details have been emailed to you.